Log in

NYSE:SEMSelect Medical Stock Price, Forecast & News

$16.40
-0.78 (-4.54 %)
(As of 05/29/2020 04:00 PM ET)
Add
Compare
Today's Range
$16.33
Now: $16.40
$17.47
50-Day Range
$13.58
MA: $15.55
$17.23
52-Week Range
$10.00
Now: $16.40
$28.61
Volume1.26 million shs
Average Volume1.09 million shs
Market Capitalization$2.20 billion
P/E Ratio13.67
Dividend YieldN/A
Beta1.48
Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates through four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra. The Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious disease, respiratory failure and pulmonary disease, surgery requiring recovery, renal disease, neurological events, and trauma. The Rehabilitation Hospital segment offers therapy and rehabilitation treatments, including rehabilitative services for brain and spinal cord injuries, strokes, amputations, neurological disorders, orthopedic conditions, pediatric congenital or acquired disabilities, and cancer. The Outpatient Rehabilitation segment operates rehabilitation clinics that provide physical, occupational, and speech rehabilitation programs and services; and specialized programs, such as functional programs for work related injuries, hand therapy, post-concussion rehabilitation, and athletic training services. The Concentra segment operates and provides medical centers and contract services at employer worksites and Department of Veterans Affairs community-based outpatient clinics (CBOCs) that deliver occupational medicine, consumer health, physical therapy, and veteran's healthcare services. As of December 31, 2018, the company operated 96 critical illness recovery hospitals in 27 states; 26 rehabilitation hospitals in 11 states; 1,662 facilities in 37 states and the District of Columbia; and 524 occupational health centers, 124 onsite clinics at employer worksites, and 31 Department of Veterans Affairs CBOCs in 44 states. Select Medical Holdings Corporation was founded in 1996 and is headquartered in Mechanicsburg, Pennsylvania.
Read More
Select Medical logo

Beat the Market (BTM) Rank

Analyst Opinion: 4.4Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 3.1 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.13 out of 5 stars


Industry, Sector and Symbol

Industry Hospitals
Sub-IndustryHealth Care Facilities
SectorMedical
CUSIP81619Q10
Phone717-972-1100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$5.45 billion
Cash Flow$2.74 per share
Book Value$7.28 per share

Profitability

Net Income$148.45 million

Miscellaneous

Employees49,900
Market Cap$2.20 billion
Next Earnings Date8/6/2020 (Estimated)
OptionableOptionable

Receive SEM News and Ratings via Email

Sign-up to receive the latest news and ratings for SEM and its competitors with MarketBeat's FREE daily newsletter.

Select Medical (NYSE:SEM) Frequently Asked Questions

How has Select Medical's stock been impacted by COVID-19 (Coronavirus)?

Select Medical's stock was trading at $20.03 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, SEM stock has decreased by 18.1% and is now trading at $16.40. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Select Medical?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Select Medical in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Select Medical.

When is Select Medical's next earnings date?

Select Medical is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for Select Medical.

How were Select Medical's earnings last quarter?

Select Medical Holdings Co. (NYSE:SEM) announced its quarterly earnings data on Thursday, April, 30th. The health services provider reported $0.37 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.32 by $0.05. The health services provider had revenue of $1.42 billion for the quarter, compared to analysts' expectations of $1.36 billion. Select Medical had a net margin of 2.90% and a return on equity of 18.74%. Select Medical's quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.27 earnings per share. View Select Medical's earnings history.

What price target have analysts set for SEM?

5 equities research analysts have issued 12 month price targets for Select Medical's shares. Their forecasts range from $18.00 to $26.00. On average, they expect Select Medical's stock price to reach $23.40 in the next year. This suggests a possible upside of 42.7% from the stock's current price. View analysts' price targets for Select Medical.

Has Select Medical been receiving favorable news coverage?

Media headlines about SEM stock have trended very negative on Saturday, according to InfoTrie. The research group identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Select Medical earned a news impact score of -3.5 on InfoTrie's scale. They also assigned media stories about the health services provider a news buzz of 3.0 out of 10, indicating that recent news coverage is unlikely to have an effect on the company's share price in the near future. View the latest news aboutSelect Medical.

Are investors shorting Select Medical?

Select Medical saw a decrease in short interest in April. As of April 30th, there was short interest totaling 2,820,000 shares, a decrease of 11.9% from the April 15th total of 3,200,000 shares. Based on an average trading volume of 1,180,000 shares, the short-interest ratio is presently 2.4 days. Approximately 2.6% of the company's shares are short sold. View Select Medical's Current Options Chain.

Who are some of Select Medical's key competitors?

What other stocks do shareholders of Select Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Select Medical investors own include Alibaba Group (BABA), AT&T (T), Netflix (NFLX), AbbVie (ABBV), Intel (INTC), Johnson & Johnson (JNJ), Walt Disney (DIS), salesforce.com (CRM), Cisco Systems (CSCO) and NVIDIA (NVDA).

Who are Select Medical's key executives?

Select Medical's management team includes the following people:
  • Mr. Robert A. Ortenzio, Co-Founder & Exec. Chairman (Age 61)
  • Mr. David S. Chernow, Pres & CEO (Age 62)
  • Mr. Rocco A. Ortenzio, Co-Founder & Vice Chairman (Age 86)
  • Mr. Martin F. Jackson, Exec. VP & CFO (Age 64)
  • Mr. Michael E. Tarvin, Exec. VP, Gen. Counsel & Sec. (Age 58)

What is Select Medical's stock symbol?

Select Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "SEM."

Who are Select Medical's major shareholders?

Select Medical's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (12.73%), State Street Corp (2.69%), Geode Capital Management LLC (1.23%), Nuveen Asset Management LLC (1.20%), Victory Capital Management Inc. (1.15%) and Victory Capital Management Inc. (1.15%). Company insiders that own Select Medical stock include David S Chernow, James S Ely III, Leopold Swergold, Michael E Tarvin, Robert A Ortenzio, Robert G Breighner Jr, Rocco A Ortenzio and Scott A Romberger. View institutional ownership trends for Select Medical.

Which institutional investors are selling Select Medical stock?

SEM stock was sold by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Victory Capital Management Inc., Canada Pension Plan Investment Board, Engineers Gate Manager LP, Parametric Portfolio Associates LLC, Bank of New York Mellon Corp, Deutsche Bank AG, and Fuller & Thaler Asset Management Inc.. Company insiders that have sold Select Medical company stock in the last year include David S Chernow, Leopold Swergold, Michael E Tarvin, Robert A Ortenzio, Robert G Breighner Jr, and Scott A Romberger. View insider buying and selling activity for Select Medical.

Which institutional investors are buying Select Medical stock?

SEM stock was bought by a variety of institutional investors in the last quarter, including Invesco Ltd., Morgan Stanley, Morgan Stanley, Martingale Asset Management L P, Robeco Institutional Asset Management B.V., WINTON GROUP Ltd, Grantham Mayo Van Otterloo & Co. LLC, and KBC Group NV. View insider buying and selling activity for Select Medical.

How do I buy shares of Select Medical?

Shares of SEM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Select Medical's stock price today?

One share of SEM stock can currently be purchased for approximately $16.40.

How big of a company is Select Medical?

Select Medical has a market capitalization of $2.20 billion and generates $5.45 billion in revenue each year. The health services provider earns $148.45 million in net income (profit) each year or $1.24 on an earnings per share basis. Select Medical employs 49,900 workers across the globe.

What is Select Medical's official website?

The official website for Select Medical is www.selectmedicalcorp.com.

How can I contact Select Medical?

Select Medical's mailing address is 4714 GETTYSBURG ROAD P.O. BOX 2034, MECHANICSBURG PA, 17055. The health services provider can be reached via phone at 717-972-1100 or via email at [email protected]

This page was last updated on 5/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.